Brief: Neogenomics Inc Reaffirms Full-Year 2025 Guidance
18/02/2025 12:19
Feb 18 (Reuters) - Neogenomics Inc NEO.O :
* REAFFIRMS FULL-YEAR 2025 GUIDANCE
* QTRLY LOSS PER SHARE $0.12
* FY2025 EARNINGS PER SHARE VIEW $0.20, REVENUE VIEW $733.0
MILLION -- LSEG IBES DATA
* Q4 EARNINGS PER SHARE VIEW $0.03 -- LSEG IBES DATA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeoGenomics
See all newsU.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
U.S. STOCKS ON THE MOVE-Constellation Energy, AMD
NeoGenomics rises after BTIG upgrades to 'buy'
Brief: Neogenomics Announces Executive Leadership And Board Of Directors Succession Plan
Brief: Neogenomics Receives Medicare Coverage For Radar St For Immunotherapy Treatment Response Monitoring